معرفی
Bin Zhang, MD, PhD, is a Professor at the Feinberg School of Medicine, Northwestern University, specializing in Cancer Immunology, Hematology/Oncology, Microbiology-Immunology, and Pathology. He serves as the Johanna Dobe Professor of Cancer Immunology and leads an integrated translational research program focused on tumor immune evasion mechanisms and immunotherapy development.
- Center for Human Immunobiology
- Northwestern Clinical and Translational Sciences Institute (NUCATS)
- Robert H. Lurie Comprehensive Cancer Center
- Robert J. Havey Institute for Global Health
- Skin Biology and Diseases Resource-Based Center
His research spans lipid metabolism in immune cells, CD73 ectoenzyme interactions, epigenetic priming, and protein regulation in immunosuppressive tumor environments. Key innovations include ultrasound-mediated blood-brain barrier penetration for glioblastoma treatment and dual inhibition strategies targeting TG2 enzyme.
Recent publications emphasize molecular mechanisms in triple-negative breast cancer immune evasion (2025), T-cell activation dynamics (2025), and ovarian cancer disparities (2024). His work integrates cutting-edge technical platforms across immunology, oncology, and translational research.
- Scientific Awards: Johanna Dobe Professor of Cancer Immunology
As director of the Cancer Immunology and Immunotherapy Initiative, he fosters collaboration among Feinberg investigators. Industry relationships include consulting with Flashpoint Therapeutics and ownership in B.J. Therapeutics (2024 disclosures).
